Comparative Pharmacology
Head-to-head clinical analysis: KENALOG IN ORABASE versus QNASL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: KENALOG IN ORABASE versus QNASL.
KENALOG IN ORABASE vs QNASL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Corticosteroid that binds to glucocorticoid receptors, modulating gene expression to reduce inflammation, suppress immune response, and inhibit fibroblast proliferation.
Beclomethasone dipropionate is a corticosteroid with anti-inflammatory activity. It binds to glucocorticoid receptors, inhibiting inflammatory mediators such as prostaglandins and leukotrienes, and reducing nasal inflammation.
Apply a thin layer to the affected area 2-4 times daily, after meals and at bedtime. Do not rub in; allow to form a film.
1 to 2 sprays (80 mcg/spray) per nostril once daily; maximum 2 sprays/nostril/day.
None Documented
None Documented
Terminal half-life approximately 2-5 hours following mucosal application.
The terminal elimination half-life is approximately 8-10 hours in healthy adults, supporting twice-daily administration for systemic effects; however, intranasal administration results in minimal systemic absorption, and local half-life in nasal tissues is not well characterized.
Primarily hepatic metabolism; metabolites excreted renally (~75%) and in feces (~10%).
The majority of a dose (approximately 40-50%) is excreted in feces as unchanged drug and metabolites, with about 10-15% excreted in urine as metabolites. Biliary excretion is the primary route of elimination.
Category C
Category C
Corticosteroid
Corticosteroid